Results from the BETTER WISE trial: a pragmatic cluster two arm parallel randomized controlled trial for primary prevention and screening in primary care during the COVID-19 pandemic

Table 5 The impact of the COVID-19 pandemic on the composite outcome score by randomization group

Control		Intervention		P-value*
Patients (N)	Composite Score (Mean, 95% CI)	Patients (N)	Composite Score (Mean, 95% CI)
67	21.3 (13.2, 29.3)	69	42.1 (30.8, 53.4)	0.003

Composite score: defined as the ratio of the number of cancer and chronic disease prevention and screening actions met according to pre-defined targets to the number of actions for which the patient was eligible. Data are difference in composite outcome relative to the reference condition for the variable. CI confidence interval
^*P values are based on two-sided Wald tests using robust covariance

ISSN: 2731-4553